richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
Published 5 years ago • 100 plays • Length 1:16
Download video MP4
Download video MP3
Similar videos
-
0:43
richard kim, md, on the role of braf mutations in treatment of cholangiocarcinoma
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
1:24
rachna shroff, md, expands on targeted therapies in the treatment of cholangiocarcinoma
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:47
richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
0:49
richard kim, md, considers the effectiveness of combination sorafenib and tace in hcc patients
-
19:03
ac21 - richard kim: which cholangiocarcinoma patients benefit from immunotherapy?
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
1:33
richard kim, md, offers analysis of the rainfall study in metastatic gastric & ge junction cancer
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
3:45
molecular target therapy in pancreatic and liver cancer
-
43:44
cholangiocarcinoma and gallbladder cancer 2023
-
33:05
treatment of intrahepatic cholangiocarcinoma: a disease on the rise
-
1:12
richard finn, md, shares his thoughts on the role of systemic therapy in hcc
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
1:25
richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
-
4:08
case 3: third-line therapy for metastatic crc
Clip.africa.com - Privacy-policy